Pharmaceuticals
Govt sets goal higher for India’s nutraceutical industry
08 Nov 2024
India is set to play a major role in the global nutraceutical industry, with its wealth of traditional knowledge, its Ayurveda system and policy support, as per government projections.
Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs
30 Oct 2024
The maximum retail prices (MRP) of three main drugs used in the treatment of cancer, viz, Trastuzumab, Osimertinib and Durvalumab
Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious
27 Oct 2024
A routine inspection by the Central Drug Regulatory Authority of retail medical shops in select locations of Odisha
.webp)
Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences
24 Oct 2024
US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion
NPPA hikes ceiling prices of 8 essential drugs by 50%
16 Oct 2024
National Pharmaceutical Pricing Authority (NPPA) has approved a 50 per cent increase in the ceiling prices of 11 scheduled formulations of eight drugs
Novartis India refutes media reports of negotiations with Alkem Labs
27 Sep 2024
Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.
Mankind Pharma to buy Bharat Serums and Vaccines in a Rs13,630-cr deal
27 Jul 2024
Mankind Pharma is acquiring Bharat Serums and Vaccines (BVS) from private equity firm Advent International in a deal valued at Rs13,630 crore.
AstraZeneca starts global recall of its controversial Covid 19 vaccine
08 May 2024
Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca
Novartis to acquire US-based Mariana Oncology in $1.75 bn deal
03 May 2024
Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.
Chinese industrial goods accounted for 30% of India’s 2023-24 imports: GTRI report
29 Apr 2024
China's share in India's industrial goods imports jumped to 30 per cent in 2023-24 from 21 per cent over the 15-year period between 2008-09 and 2023-24, as per a report published by Global Trade Research Initiative (GTRI).
.webp)
.webp)
